Boston Scientific Corporation - stock earnings
BSX Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 AfterMarket | 0.56 / 0.52 | 3.6 billion | - / 3.7 billion | 3.7 billion |
BSX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q1 | 494.0 million USD | 3.9 billion USD |
| 2023Q4 | 505.0 million USD | 3.7 billion USD |
| 2023Q3 | 504.0 million USD | 3.5 billion USD |
| 2023Q2 | 270.0 million USD | 3.6 billion USD |
| 2023Q1 | 314.0 million USD | 3.4 billion USD |
| 2022Q4 | 140.0 million USD | 3.2 billion USD |
| 2022Q3 | 174.0 million USD | 3.2 billion USD |
| 2022Q2 | 246.0 million USD | 3.2 billion USD |
| 2022Q1 | 96.0 million USD | 3.0 billion USD |
| 2021Q4 | 94.0 million USD | 3.1 billion USD |
| 2021Q3 | 419.0 million USD | 2.9 billion USD |
| 2021Q2 | 186.0 million USD | 3.1 billion USD |
| 2021Q1 | 341.0 million USD | 2.8 billion USD |
| 2020Q4 | 152.0 million USD | 2.7 billion USD |
| 2020Q3 | -155.0 million USD | 2.7 billion USD |
| 2020Q2 | -147.0 million USD | 2.0 billion USD |
| 2020Q1 | 11.0 million USD | 2.5 billion USD |
| 2019Q4 | 4.0 billion USD | 2.9 billion USD |
| 2019Q3 | 126.0 million USD | 2.7 billion USD |
| 2019Q2 | 154.0 million USD | 2.6 billion USD |
| 2019Q1 | 424.0 million USD | 2.5 billion USD |
| 2018Q4 | 386.0 million USD | 2.6 billion USD |
| 2018Q3 | 432.0 million USD | 2.4 billion USD |
| 2018Q2 | 555.0 million USD | 2.5 billion USD |
| 2018Q1 | 298.0 million USD | 2.4 billion USD |
| 2017Q4 | -615.0 million USD | 2.4 billion USD |
| 2017Q3 | 283.0 million USD | 2.2 billion USD |
| 2017Q2 | 146.0 million USD | 2.3 billion USD |
| 2017Q1 | 290.0 million USD | 2.2 billion USD |
| 2016Q4 | 124.0 million USD | 2.2 billion USD |
| 2016Q3 | 228.0 million USD | 2.1 billion USD |
| 2016Q2 | -207.0 million USD | 2.1 billion USD |
| 2016Q1 | 202.0 million USD | 2.0 billion USD |
| 2015Q4 | -142.0 million USD | 2.0 billion USD |
| 2015Q3 | -198.0 million USD | 1.9 billion USD |
| 2015Q2 | 102.0 million USD | 1.8 billion USD |
| 2015Q1 | -1.0 million USD | 1.8 billion USD |
| 2014Q4 | 87.0 million USD | 1.9 billion USD |
| 2014Q3 | 43.0 million USD | 1.8 billion USD |
| 2014Q2 | 4.0 million USD | 1.9 billion USD |
| 2014Q1 | 133.0 million USD | 1.8 billion USD |
| 2013Q4 | 108.0 million USD | 1.8 billion USD |
| 2013Q3 | -5.0 million USD | 1.7 billion USD |
| 2013Q2 | 130.0 million USD | 1.8 billion USD |
| 2013Q1 | -354.0 million USD | 1.8 billion USD |
| 2012Q4 | 60.0 million USD | 1.8 billion USD |
| 2012Q3 | -725.0 million USD | 1.7 billion USD |
| 2012Q2 | -3.4 billion USD | 1.8 billion USD |
| 2012Q1 | 113.0 million USD | 1.9 billion USD |
| 2011Q4 | 107.0 million USD | 1.8 billion USD |
| 2011Q3 | 142.0 million USD | 1.9 billion USD |
| 2011Q2 | 146.0 million USD | 2.0 billion USD |
| 2011Q1 | 20.0 million USD | 1.9 billion USD |
| 2010Q4 | 236.0 million USD | 2.0 billion USD |
| 2010Q3 | 190.0 million USD | 1.9 billion USD |
| 2010Q2 | 98.0 million USD | 1.9 billion USD |
| 2010Q1 | -1.6 billion USD | 2.0 billion USD |
| 2009Q4 | -1.1 billion USD | 2.1 billion USD |
| 2009Q3 | 200.0 million USD | 2.0 billion USD |
| 2009Q2 | 158.0 million USD | 2.1 billion USD |
| 2009Q1 | -13.0 million USD | 2.0 billion USD |
| 2008Q4 | -2.4 billion USD | 2.0 billion USD |
| 2008Q3 | -62.0 million USD | 2.0 billion USD |
| 2008Q2 | 98.0 million USD | 2.0 billion USD |
| 2008Q1 | 322.0 million USD | 2.0 billion USD |
| 2007Q4 | -458.0 million USD | 2.2 billion USD |
| 2007Q3 | -272.0 million USD | 2.0 billion USD |
| 2007Q2 | 115.0 million USD | 2.1 billion USD |
| 2007Q1 | 120.0 million USD | 2.1 billion USD |
| 2006Q4 | 277.0 million USD | 2.1 billion USD |
| 2006Q3 | 76.0 million USD | 2.0 billion USD |
| 2006Q2 | -4.3 billion USD | 2.1 billion USD |
| 2006Q1 | 332.0 million USD | 1.6 billion USD |
| 2005Q4 | 334.0 million USD | 1.5 billion USD |
| 2005Q3 | -269.0 million USD | 1.5 billion USD |
| 2005Q2 | 205.0 million USD | 1.6 billion USD |
| 2005Q1 | 358.0 million USD | 1.6 billion USD |
| 2004Q4 | 297.0 million USD | 1.6 billion USD |
| 2004Q3 | 258.0 million USD | 1.5 billion USD |
| 2004Q2 | 313.0 million USD | 1.5 billion USD |
| 2004Q1 | 194.0 million USD | 1.1 billion USD |
| 2003Q4 | 137.0 million USD | 939.0 million USD |
| 2003Q3 | 124.0 million USD | 876.0 million USD |
| 2003Q2 | 114.0 million USD | 854.0 million USD |
| 2003Q1 | 97.0 million USD | 807.0 million USD |
| 2002Q4 | 105.0 million USD | 814.0 million USD |
| 2002Q3 | 161.0 million USD | 722.0 million USD |
| 2002Q2 | 25.0 million USD | 708.0 million USD |
| 2002Q1 | 82.0 million USD | 675.0 million USD |
| 2001Q4 | 65.0 million USD | 677.0 million USD |
| 2001Q3 | 58.0 million USD | 670.0 million USD |
| 2001Q2 | -172.0 million USD | 672.0 million USD |
| 2001Q1 | 60.0 million USD | 638.0 million USD |
| 2000Q4 | 60.0 million USD | 638.0 million USD |
| 2000Q3 | 85.0 million USD | 652.0 million USD |
| 2000Q2 | 122.0 million USD | 695.0 million USD |
| 2000Q1 | 106.0 million USD | 679.0 million USD |
| 1999Q4 | 107.0 million USD | 717.0 million USD |
| 1999Q3 | 55.0 million USD | 691.0 million USD |
| 1999Q2 | 109.0 million USD | 726.0 million USD |
| 1999Q1 | 100.0 million USD | 708.0 million USD |
| 1998Q4 | 99.4 million USD | 682.5 million USD |
| 1998Q3 | -509.4 million USD | 575.4 million USD |
| 1998Q2 | 78.7 million USD | 505.7 million USD |
| 1998Q1 | 66.9 million USD | 470.0 million USD |
| 1997Q4 | 2.4 million USD | 493.2 million USD |
| 1997Q3 | 88.4 million USD | 474.8 million USD |
| 1997Q2 | -26.9 million USD | 473.7 million USD |
| 1997Q1 | 72.6 million USD | 399.2 million USD |
| 1996Q4 | 76.7 million USD | 408.7 million USD |
| 1996Q3 | 67.8 million USD | 373.7 million USD |
| 1996Q2 | 23.5 million USD | 357.2 million USD |
| 1996Q1 | -1.0 million USD | 322.4 million USD |
| 1995Q4 | -16.3 million USD | 431.2 million USD |
| 1995Q3 | 47.0 million USD | 232.8 million USD |
| 1995Q2 | 45.9 million USD | 227.3 million USD |
| 1995Q1 | -68.6 million USD | 215.7 million USD |
| 1994Q4 | 23.1 million USD | 121.6 million USD |
| 1994Q3 | 19.8 million USD | 112.2 million USD |
| 1994Q2 | 18.8 million USD | 109.9 million USD |
| 1994Q1 | 18.0 million USD | 105.3 million USD |
| 1993Q4 | 20.3 million USD | 101.1 million USD |
| 1993Q3 | 17.3 million USD | 95.6 million USD |
| 1993Q2 | 16.8 million USD | 94.4 million USD |
| 1993Q1 | 15.3 million USD | 88.9 million USD |
| 1992Q4 | 15.6 million USD | 84.4 million USD |
| 1992Q3 | 15.2 million USD | 81.9 million USD |
| 1992Q2 | 13.3 million USD | 76.3 million USD |
| 1992Q1 | 12.5 million USD | 72.6 million USD |
| 1991Q4 | 10.6 million USD | 63.8 million USD |
| 1991Q3 | 10.9 million USD | 59.9 million USD |
| 1991Q2 | 10.8 million USD | 55.9 million USD |
| 1991Q1 | 9.5 million USD | 50.5 million USD |
BSX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 1.6 billion USD | 14.2 billion USD |
| 2022 | 698.0 million USD | 12.7 billion USD |
| 2021 | 1.0 billion USD | 11.9 billion USD |
| 2020 | -140.0 million USD | 9.9 billion USD |
| 2019 | 4.7 billion USD | 10.7 billion USD |
| 2018 | 1.7 billion USD | 9.8 billion USD |
| 2017 | 104.0 million USD | 9.0 billion USD |
| 2016 | 347.0 million USD | 8.4 billion USD |
| 2015 | -239.0 million USD | 7.5 billion USD |
| 2014 | 267.0 million USD | 7.4 billion USD |
| 2013 | -121.0 million USD | 7.1 billion USD |
| 2012 | -4.1 billion USD | 7.2 billion USD |
| 2011 | 441.0 million USD | 7.6 billion USD |
| 2010 | -1.1 billion USD | 7.8 billion USD |
| 2009 | -1.0 billion USD | 8.2 billion USD |
| 2008 | -2.1 billion USD | 8.1 billion USD |
| 2007 | -495.0 million USD | 8.4 billion USD |
| 2006 | -3.6 billion USD | 7.8 billion USD |
| 2005 | 628.0 million USD | 6.3 billion USD |
| 2004 | 1.1 billion USD | 5.6 billion USD |
| 2003 | 472.0 million USD | 3.5 billion USD |
| 2002 | 373.0 million USD | 2.9 billion USD |
| 2001 | -54.0 million USD | 2.7 billion USD |
| 2000 | 373.0 million USD | 2.7 billion USD |
| 1999 | 371.0 million USD | 2.8 billion USD |
| 1998 | -264.4 million USD | 2.2 billion USD |
| 1997 | 139.3 million USD | 1.9 billion USD |
| 1996 | 167.1 million USD | 1.5 billion USD |
| 1995 | 8.0 million USD | 1.1 billion USD |
| 1994 | 79.7 million USD | 448.9 million USD |
| 1993 | 69.7 million USD | 380.1 million USD |
| 1992 | 56.6 million USD | 315.2 million USD |
| 1991 | 41.8 million USD | 230.0 million USD |
BSX
Price: $72.86
52 week price:
Payout Ratio Range:
Earnings Per Share: 1.07 USD
P/E Ratio: 61.64
Exchange: NYQ
Sector: Healthcare
Industry: Medical Devices
Volume: 13.0 million
Ebitda: 425.0 millionMarket Capitalization: 107.2 billion